Back
Viking Therapeutics Stock Predictions
Sponsored
VKTX
Sponsored
32,481% Growth? Meet Mode Mobile's "EarnPhone"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
80
VKTX
Viking Therapeutics
Last Price:
68.17
Seasonality Move:
18.2%
7 Day Trial
ALL ACCESS PASS
$
7
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pmViking Therapeutics Stock Forecast
- Over the next 52 weeks, Viking Therapeutics has on average historically risen by 143.4% based on the past 9 years of stock performance.
- Viking Therapeutics has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
-
Is Viking Therapeutics Stock Undervalued?
The current Viking Therapeutics [VKTX] share price is $64.46. The Score for VKTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal. - VKTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
Will Viking Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Viking Therapeutics has on average historically risen by 143.4% based on the past 9 years of stock performance.
Viking Therapeutics Stock Rating
Buy
80
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics overpriced?
- Viking Therapeutics has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
Viking Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vikingtherapeutics.com
52-Week Data
52-Week High:
99.41
52-Week Low:
8.28
Prediction Charts
Market Cap:
7.14B
Price in USD:
64.46
Volume:
2.13M
Beta:
1.33
Technical Analysis
SMA50:
58.50
SMA100:
60.31
SMA200:
52.22
52-Wk Change:
366.59%
Stock Predictions
-
Is Viking Therapeutics stock public?
Yes, Viking Therapeutics is a publicly traded company. -
What is the Viking Therapeutics stock quote today?
The Viking Therapeutics stock price is 64.46 USD today. -
How to buy Viking Therapeutics stock online?
You can buy Viking Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Aug-29 | 61.29 | 62.65 | 64.16 | 61.25 |
Aug-30 | 62.66 | 64.14 | 64.91 | 60.78 |
Sep-3 | 63.70 | 58.39 | 64.64 | 58.11 |
Sep-4 | 58.20 | 58.10 | 60.27 | 57.57 |
Sep-5 | 57.72 | 55.39 | 58.38 | 54.51 |
Sep-6 | 55.47 | 54.16 | 55.63 | 51.70 |
Sep-9 | 56.29 | 54.88 | 56.37 | 53.92 |
Sep-10 | 54.73 | 54.65 | 55.35 | 52.70 |
Sep-11 | 57.23 | 60.83 | 61.11 | 55.92 |
Sep-12 | 62.71 | 62.76 | 64.66 | 62.06 |
Sep-13 | 63.08 | 66.73 | 67.94 | 62.63 |
Sep-16 | 66.21 | 67.10 | 68.83 | 64.54 |
Sep-17 | 66.12 | 62.94 | 67.06 | 62.20 |
Sep-18 | 63.05 | 64.46 | 66.05 | 62.62 |
Viking Therapeutics Earnings
Viking Therapeutics Earnings Report: Per Share Viking Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Viking Therapeutics Forecast Revenue Growth
Viking Therapeutics Stock Analysis: Historical quarterly revenues per share for Viking Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.55 per share.
* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.